|
| |
Image Results
Loading...
Loading...
CANGENE CORP Pages on BioPortfolio:
Results from other life science and pharmaceutical sites:
CANGENE CORP. - Google Finance
Get the latest on CANGENE CORP. including up to date news, high quality discussion groups and more on Google Finance.
http://www.google.com/finance?q=ETR:YGE...
|
Cangene Corporation Acquires U.S. Commercialization Rights for ...
20 Oct 2009 ... TORONTO and WINNIPEG, Oct. 19 /CNW/ - Cangene Corporation today announces that it has signed an agreement with its majority shareholder, ...
http://www.biospace.com/news_story.aspx?NewsEntityId=159674...
|
Apotex - Wikipedia, the free encyclopedia
20 Sep 2009 ... Apotex owns 61% of Cangene Corp., a Winnipeg-based biopharmaceutical company, according to Cangene's 2007 annual report. ...
http://en.wikipedia.org/wiki/Apotex...
|
BioSpace - Cangene Corporation News, Search Jobs, Events
20 Oct 2009 ... Cangene Corporation 104 Chancellor Matheson Road Winnipeg Manitoba R3T 5Y3 Canada Phone: 204-275-4200 Fax: ...
http://www.biospace.com/company_profile.aspx?CompanyId=4200...
|
Cangene to host fiscal 2009 conference call on Thursday October 22 ...
20 Oct 2009 ... TORONTO and WINNIPEG, Oct. 20 /CNW/ - Cangene Corporation today announces that it intends to host a conference call on Thursday, October 22, ...
http://biz.yahoo.com/cnw/091020/cangene_confrnce_call.html?....
|
Cangene Corporation Acquires Twinstrand Therapeutics - News ...
8 Jul 2009 ... TORONTO and WINNIPEG, July 7 /CNW/ - Cangene Corporation today announces that it has acquired all issued and outstanding shares of privately ...
http://www.biospace.com/news_story.aspx?NewsEntityId=149213...
|
m51(03)q '+*.m -—-
Page 2 – Cangene Corporation. 3. Failure to establish and~ol-low sampling a~d testing plans in written procedures to include the method of sampling and the ...
http://www.fda.gov/downloads/ICECI/EnforcementActions/Warnin...
|
Cangene Corporation's Human Growth Hormone Drug Submission Is ...
CONTACT: about Cangene Corporation, please contact Jean Compton, Manager, Investor Relations, (905) 405-2900, or by email at jcompton@cangene.com ...
http://www.biospace.com/news_story.aspx?NewsEntityId=24404...
|
Label - Vaccinia Immune Globulin Intravenous (Human) (VIGIV ...
physician or other health care provider to Cangene Corporation at 1-877- ..... Unpublished data on file, VA-002 Final Study Report, Cangene Corporation. ...
http://www.fda.gov/downloads/BiologicsBloodVaccines/BloodBlo...
|
Cangene Corporation Opts to Exit European Market with WinRho(R ...
31 Jul 2009 ... TORONTO and WINNIPEG, July 30 /CNW/ - Cangene Corporation today announces that it has withdrawn its Marketing Authorization Applications ...
http://www.biospace.com/news_story.aspx?NewsEntityId=151836...
|
|